Gold R - Search Results

1

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Fox RJ, Cree BA, De Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Kaufman M, Montalbán X, Weinstock-Guttman B, Anderson B, Natarajan A, Ticho B, Duda P; RESTORE. Fox RJ, et al. Among authors: gold r. Neurology. 2014 Apr 29;82(17):1491-8. doi: 10.1212/WNL.0000000000000355. Epub 2014 Mar 28. Neurology. 2014. PMID: 24682966 Free PMC article. Clinical Trial.

2

Circulating adhesion molecules and inflammatory mediators in demyelination: a review.

Hartung HP, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners KH, Toyka KV. Hartung HP, et al. Among authors: gold r. Neurology. 1995 Jun;45(6 Suppl 6):S22-32. doi: 10.1212/wnl.45.6_suppl_6.s22. Neurology. 1995. PMID: 7783908 Review.

3

[Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].

Gold R, Hartung HP, Toyka KV. Gold R, et al. Fortschr Neurol Psychiatr. 1995 Jan;63(1):17-29. doi: 10.1055/s-2007-996599. Fortschr Neurol Psychiatr. 1995. PMID: 7883268 Review. German.

4

Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat.

Zettl UK, Gold R, Hartung HP, Toyka KV. Zettl UK, et al. Among authors: gold r. Neurosci Lett. 1994 Jul 18;176(1):75-9. doi: 10.1016/0304-3940(94)90875-3. Neurosci Lett. 1994. PMID: 7970241

5

H2O2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts.

Stangel M, Zettl UK, Mix E, Zielasek J, Toyka KV, Hartung HP, Gold R. Stangel M, et al. Among authors: gold r. J Neuropathol Exp Neurol. 1996 Jan;55(1):36-43. doi: 10.1097/00005072-199601000-00004. J Neuropathol Exp Neurol. 1996. PMID: 8558170

6

Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro.

Gold R, Zielasek J, Kiefer R, Toyka KV, Hartung HP. Gold R, et al. Cell Immunol. 1996 Feb 25;168(1):69-77. doi: 10.1006/cimm.1996.0050. Cell Immunol. 1996. PMID: 8599841

7

Symptomatic hyperekplexia in a patient with multiple sclerosis.

Ruprecht K, Warmuth-Metz M, Waespe W, Gold R. Ruprecht K, et al. Among authors: gold r. Neurology. 2002 Feb 12;58(3):503-4. doi: 10.1212/wnl.58.3.503. Neurology. 2002. PMID: 11839869 No abstract available.

8

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.

Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. Kieseier BC, et al. Among authors: gold r. Muscle Nerve. 2004 Aug;30(2):131-56. doi: 10.1002/mus.20076. Muscle Nerve. 2004. PMID: 15266629 Review.

9

Towards individualised multiple-sclerosis therapy.

Gold R, Hartung HP. Gold R, et al. Lancet Neurol. 2005 Nov;4(11):693-4. doi: 10.1016/S1474-4422(05)70205-2. Lancet Neurol. 2005. PMID: 16239174 No abstract available.

10

Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.

Stasiolek M, Bayas A, Kruse N, Wieczarkowiecz A, Toyka KV, Gold R, Selmaj K. Stasiolek M, et al. Among authors: gold r. Brain. 2006 May;129(Pt 5):1293-305. doi: 10.1093/brain/awl043. Epub 2006 Mar 2. Brain. 2006. PMID: 16513684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,011 results

Search Page